Establishment of Mouse Model of MYH9 Disorders: Heterozygous R702C Mutation Provokes Macrothrombocytopenia with Leukocyte Inclusion Bodies, Renal Glomerulosclerosis and Hearing Disability

New players in the pathogenesis of focal segmental glomerulosclerosis

(2012) C. Schell et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Heterozygous ITGA2B R995W mutation inducing constitutive activation of the  IIb 3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia

(2011) S. Kunishima et al.   BLOOD

Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A

(2011) Y. Zhang et al.   BLOOD

Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias

(2011) Carlo L. Balduini et al.   BRITISH JOURNAL OF HAEMATOLOGY

Podocyte-Specific Deletion of Myh9 Encoding Nonmuscle Myosin Heavy Chain 2A Predisposes Mice to Glomerulopathy

(2011) D. B. Johnstone et al.   MOLECULAR AND CELLULAR BIOLOGY

Advances in the understanding of MYH9 disorders

(2010) Shinji Kunishima et al.   CURRENT OPINION IN HEMATOLOGY

Patients with Epstein–Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease

(2010) Takashi Sekine et al.   KIDNEY INTERNATIONAL

Mac-1 (CD11b/CD18) Links Inflammation and Thrombosis After Glomerular Injury

(2009) Junichi Hirahashi et al.   CIRCULATION

Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders

(2008) S. Kunishima et al.   BLOOD

Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history ofMYH9-related disease

(2007) Alessandro Pecci et al.   HUMAN MUTATION